Shown, not claimed.
Every story here is published with written permission, named tenure, and the same caveat: results vary.
The wall, on the record.
Story reserved. Published only with written permission.
Results vary.
Story reserved. Published only with written permission.
Results vary.
Story reserved. Published only with written permission.
Results vary.
Story reserved. Published only with written permission.
Results vary.
Story reserved. Published only with written permission.
Results vary.
Story reserved. Published only with written permission.
Results vary.
A decade of coaching preceded this site. Stories appear as members grant permission, with their tenure and their terms. We would rather show three true things than thirty borrowed ones.
We publish numbers when they are real.
Our partner protocol tracks lean mass across enhancement arcs, read from the InBody and DEXA hardware clinics already own.
We will publish those numbers when they are real, and not before. No borrowed screenshots, no rounded-up averages, no invented averages standing in for a member who does not exist.
The argument for the work is already peer-reviewed.
of weight lost on semaglutide can be lean mass.1
of muscle mass lost over 68 to 72 weeks by phase 3 GLP-1/GIP participants: roughly 20 years of age-related loss.2
of daily protein, plus resistance training: the peer-reviewed countermeasures.3
1. STEP-1 DXA substudy: 6.92 kg of 17.32 kg lost was lean mass; independently reconfirmed at ENDO 2025 (Mass General / Harvard). 2. Phase 3 GLP-1/GIP trial data, muscle loss across 68 to 72 weeks. 3. Obesity Reviews, 2025. Individual results vary. Questions about any medication belong with your prescriber. We coach the work around it.
THE RESULT IS THE ARGUMENT.
When the proof is real, it will be here, with a name and a tenure on it. Until then, start yours.